This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

Microbial products and their effects on the patient. Version 1 COVID 19

  • Research type

    Research Study

  • Full title

    The detection of microbial products and the effects on patients in infection COVID 19

  • IRAS ID

    162013

  • Contact name

    Becky Ward

  • Contact email

    becky.ward@imperial.ac.uk

  • Sponsor organisation

    Imperial College London

  • Research summary

    Can bacterial products be detected in body fluids or tissues during infection?\nBacteria produce a number of exoproteins that can be detected during broth growth, and we seek to identify them now in clinical infection.[COVID-19 amendment – 03/04/2020] Intention of project is to include samples from patients with COVID19 as well as other acute infections hence terminology is altered to reflect this (“bacterial“ changed to “microbial“). 2.Amendment requested to allow sharing of samples with Imperial colleagues to undertake work detailed in protocol. \n3. New end date requested (31st March 2025)- new funding obtained via NIHR HPRU in AMR and HCAI awarded April 2020 for 5 years

  • REC name

    London - West London & GTAC Research Ethics Committee

  • REC reference

    06/Q0406/20

  • Date of REC Opinion

    26 Apr 2006

  • REC opinion

    Favourable Opinion